Quick Answer
Acadia Healthcare Company, Inc. reported Cash and Equivalents of $133.24 million for fiscal year 2025.
Acadia Healthcare Company, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $133.24M | +74.6% |
| 2024 | $76.31M | -23.8% |
| 2023 | $100.07M | +2.5% |
| 2022 | $97.65M | -27.0% |
| 2021 | $133.81M | -64.7% |
| 2020 | $378.70M | +280.5% |
| 2019 | $99.53M | +97.1% |
| 2018 | $50.51M | -24.9% |
| 2017 | $67.29M | +17.9% |
| 2016 | $57.06M | +408.8% |
| 2015 | $11.21M | -88.1% |
| 2014 | $94.04M | +1958.2% |
| 2013 | $4.57M | -90.8% |
| 2012 | $49.40M | -19.2% |
| 2011 | $61.12M | +609.5% |
| 2010 | $8.61M | +91.9% |
| 2009 | $4.49M | +9875.6% |
| 2008 | $45.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $118.69M | +44.5% | -9.7% |
| June 30, 2025 | $131.42M | +70.3% | +44.0% |
| March 31, 2025 | $91.24M | +18.0% | +19.6% |
| December 31, 2024 | $76.31M | -23.8% | -7.1% |
| September 30, 2024 | $82.14M | -17.5% | +6.5% |
| June 30, 2024 | $77.17M | -31.2% | -0.2% |
| March 31, 2024 | $77.30M | +21.1% | -22.8% |
| December 31, 2023 | $100.07M | +2.5% | +0.5% |
- Acadia Healthcare Company, Inc. showed an increase of +74.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Acadia Healthcare Company, Inc.’s cash and equivalents has grown by 295993.3% (from $45.0 thousand to $133.24 million).
- The most recent figure is from Acadia Healthcare Company, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: